| Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis M Presta, P Dell’Era, S Mitola, E Moroni, R Ronca, M Rusnati Cytokine & growth factor reviews 16 (2), 159-178, 2005 | 1666 | 2005 |
| Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans M Tyagi, M Rusnati, M Presta, M Giacca Journal of Biological Chemistry 276 (5), 3254-3261, 2001 | 910 | 2001 |
| Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors P Jeannin, B Bottazzi, M Sironi, A Doni, M Rusnati, M Presta, V Maina, ... Immunity 22 (5), 551-560, 2005 | 341 | 2005 |
| Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis M Rusnati, M Camozzi, E Moroni, B Bottazzi, G Peri, S Indraccolo, ... Blood 104 (1), 92-99, 2004 | 247 | 2004 |
| Role of the soluble pattern recognition receptor PTX3 in vascular biology M Presta, M Camozzi, G Salvatori, M Rusnati Journal of cellular and molecular medicine 11 (4), 723-738, 2007 | 221 | 2007 |
| HIV-tat protein is a heparin-binding angiogenic growth factor. A Albini, R Benelli, M Presta, M Rusnati, M Ziche, A Rubartelli, ... Oncogene 12 (2), 289-297, 1996 | 206 | 1996 |
| αvβ3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells M Rusnati, E Tanghetti, P Dell’Era, A Gualandris, M Presta Molecular Biology of the Cell 8 (12), 2449-2461, 1997 | 199 | 1997 |
| Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane D Ribatti, C Urbinati, B Nico, M Rusnati, L Roncali, M Presta Developmental biology 170 (1), 39-49, 1995 | 196 | 1995 |
| Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach M Presta, P Chiodelli, A Giacomini, M Rusnati, R Ronca Pharmacology & therapeutics 179, 171-187, 2017 | 178 | 2017 |
| Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies M Rusnati, M Presta Current pharmaceutical design 13 (20), 2025-2044, 2007 | 165 | 2007 |
| Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides M Rusnati, G Tulipano, D Spillmann, E Tanghetti, P Oreste, G Zoppetti, ... Journal of Biological Chemistry 274 (40), 28198-28205, 1999 | 165 | 1999 |
| Basic fibroblast growth factor–induced angiogenic phenotype in mouse endothelium: a study of aortic and microvascular endothelial cell lines M Bastaki, EE Nelli, P Dell’Era, M Rusnati, MP Molinari-Tosatti, S Parolini, ... Arteriosclerosis, thrombosis, and vascular biology 17 (3), 454-464, 1997 | 164 | 1997 |
| Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form M Presta, JAM Maier, M Rusnati, G Ragnotti Journal of cellular physiology 140 (1), 68-74, 1989 | 164 | 1989 |
| Dendritic cell–endothelial cell cross-talk in angiogenesis S Sozzani, M Rusnati, E Riboldi, S Mitola, M Presta Trends in immunology 28 (9), 385-392, 2007 | 156 | 2007 |
| The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists M Rusnati, G Tulipano, C Urbinati, E Tanghetti, R Giuliani, M Giacca, ... Journal of Biological Chemistry 273 (26), 16027-16037, 1998 | 156 | 1998 |
| Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use P Chiodelli, A Bugatti, C Urbinati, M Rusnati Molecules 20 (4), 6342-6388, 2015 | 155 | 2015 |
| Cutting edge: proangiogenic properties of alternatively activated dendritic cells E Riboldi, T Musso, E Moroni, C Urbinati, S Bernasconi, M Rusnati, ... The Journal of Immunology 175 (5), 2788-2792, 2005 | 153 | 2005 |
| Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans: biological implications in neovascularization M Rusnati, M Presta International Journal of Clinical and Laboratory Research 26, 15-23, 1996 | 153 | 1996 |
| Basic Fribroblast Growth Factor Overexpression in Endothelial Cells: An Autocrine Mechanism for Angiogenesis and Angioproliferative Diseases A Gualandris, M Rusnati, M Bastaki, M Ziche, M Presta Vascular Endothelium: Pharmacologic and Genetic Manipulations, 263-264, 1998 | 152 | 1998 |
| Heparin derivatives as angiogenesis inhibitors M Presta, D Leali, H Stabile, R Ronca, M Camozzi, L Coco, E Moroni, ... Current pharmaceutical design 9 (7), 553, 2003 | 139 | 2003 |
